Figure 3From: The role of bisphosphonates in breast cancer: Development of bisphosphonatesEffect of nitrogen-containing bisphosphonates on the mevalonate pathway by inhibiting farnesylpyrophosphate synthase. HMG-CoA, hydroxymethylglutaryl-coenzyme A; PP, pyrophosphate. Reproduced with permission from Fleisch [28].Back to article page